admin

Increasing competition in the EV space is causing manufacturers to drop prices. That is causing EV stocks to dip as the market anticipates price drops could lead to weakening revenues and lower margins. But there is always a flip side to every story. Tesla (NASDAQ:TSLA) just lowered prices on its Model X and Model Y vehicles by $5,000 while also lowering
0 Comments
As our trusty authors have covered in detail, electric vehicle (EV) manufacturer Mullen Automotive (NASDAQ:MULN) just received what looks like a $110 million bailout. However, it’s an awfully flimsy lifeline for an automaker that’s in deep financial trouble. If you’re waiting around for MULN stock to recover, don’t hold your breath. It’s entirely possible that
0 Comments
China-based electric vehicle manufacturer Nio (NYSE:NIO) is looking to broaden its scope. However, prospective NIO stock investors should view Nio’s expansion plans with a critical eye. The company’s venture into battery-swapping technology and other fields will require time and capital (both financial and human). In the end, the results might disappoint overeager shareholders. Nio is already
0 Comments
Many investors want to make the world better while also making money. That leads us to ESG dividend stocks. These holdings fit the environmental, sustainable, and governance “ESG” framework required to be a company in good ethical standing. However, the dividend component of many ESG investments ensures that shareholders are also regularly rewarded for their investments
0 Comments
EV stocks have been the subject of investment-related conversation for years. With Tesla (NASDAQ:TSLA) constantly commanding headlines over the past five years, you’d have to live under a rock to have missed the growing EV trend. The push toward net zero is intensifying, and most agree that electric cars will be part of that transition. Governments worldwide
0 Comments
Among the things investors should like about TJX Companies (NYSE:TJX) is its popularity among working-class and middle-class consumers who are looking to save money. The apparel and home fashion retailer offers brand-name merchandise at a discount at its T.J. Maxx, Marshalls, HomeGoods, Sierra and Homesense stores and their online counterparts, appealing to a wide swath of consumers. This makes TJX
0 Comments
Shares in chip maker Intel (NASDAQ:INTC) were hammered throughout 2022, with INTC stock staying on a downward trajectory during the first two months of this year. As I have discussed previously, this was due to two factors. First, the company’s poor financial performance. Second, related to some extent to the first factor, was rising concerns about softening semiconductor
0 Comments
In this article DPZ CZR TXRH COST CRWD Follow your favorite stocksCREATE FREE ACCOUNT Domino’s will roll out 800 custom-branded 2023 Chevy Bolt electric vehicles at locations across the U.S. in the coming months. Domino’s Wall Street analysts are focusing on companies that are well-positioned to navigate the ongoing economic turmoil and emerge stronger. Here
0 Comments
While some investors love putting money down on aspirational (but unproven) enterprises in the hope of eventual growth and profitability, other market participants prefer to focus on value stocks to buy. Typically, these companies already own working enterprises. However, they just happen to be undervalued based on key performance metrics (usually trailing-12-month earnings). For this
0 Comments
Troika Media Group (NASDAQ:TRKA) has been a popular meme stock so far in 2023. Even after tanking following a short squeeze in early March, TRKA stock remains up by more than 135% year-to-date. What makes shares in this marketing company stand out among meme stocks goes beyond just the fact it has been a strong performer.
0 Comments
Adene Sanchez | E+ | Getty Images Company: Exelixis (EXEL) Business: Exelixis, an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. They have produced four marketed pharmaceutical products, including their flagship molecule, cabozantinib. Stock Market Value: $6.3B ($19.46 per share) Activist: Farallon Capital
0 Comments